Agree 1pg has a book value over 40. What a joke that is. Current...

First 46 Last

Share
Profile

Follow
TeTeTe

2,304 Posts.

02/10/15

13:35

Post #: 16104925
Share

Originally posted by MarkieMills ↑

Lets spell it out - I think some comments are due - especially before the escrow ends on the 9th Oct.
Lets assume each Source and ref client gets 5 mo for $25k - and let us assume that is in AUD, and not USD for a margin of safety.
We had 17 clients on the 29/5/15 - assume they all started bang on that day, that is 2 mo x 17 clients x 5k pcm = $170k. Add on another 2 clients for half a mo @ $5k = 5k. This alone totals $175k revenue. Then we have the other services.
In the pcp - revenue was $93k. So you would expect a minimum revenue of between $175k and $268 rock bottom minimum.
And we got $158.9k.

Now the assumptions have been stretched to get as low a number as possible here, as best I can, including no revenue from the talent and innovation for the $175 figure.

So I'd like a clarification as to how many clients are getting freebies, or how far away from reality the pro forma pricing is, or any other simple explanation as to why this does not stack up.

Hope that is simple for everybody. I'm really disinterested, but would love to short this one, if no explanation is forthcoming.

Good luck to all.

Expand

Agree 1pg has a book value over 40. What a joke that is. Current book value should be no higher than 1.5 to 2. lol I think it is a little overvalued.

1PG Price at posting: $4.64 Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

First 46 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Agree 1pg has a book value over 40. What a joke that is. Current...

Top Stories

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Monash IVF shares cater 25% – Disaster or deep-value play?

Featured News